Skip to main content
Log in

Oral administration of phytocomponent p-hydroxycinnamic acid prevents bone loss in ovariectomized rats

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The preventive effect of phytocomponent p-hydroxycinnamic acid (HCA) on ovariectomy (OVX)-induced bone loss was investigated. HCA (250 or 500 μg/100 g body weight) was orally administered once daily for 30 days to OVX rats. The analysis using a peripheral quantitative computed tomography (pQCT) showed that OVX caused bone loss in the femoral-metaphyseal tissues. This change was significantly restored after the administration of HCA (250 or 500 μg/100 g body weight) to OVX rats. Mineral content, mineral density, and polar strength strain index in the femoral-metaphyseal tissues were significantly decreased in OVX rats. These decreases were significantly restored after the administration of HCA (500 μg/100 g) to OVX rats. Moreover, OVX caused a significant decrease in calcium content or alkaline phosphatase activity in the femoral-diaphyseal and -metaphyseal tissues. These decreases were significantly restored after the administration of HCA (250 or 500 μg/100 g) to OVX rats. Deoxyribonucleic acid (DNA) content in the diaphyseal or metaphyseal tissues was significantly increased in OVX rats. These increases were significantly restored after oral administration of HCA (500 μg/100 g). This study demonstrates that HCA has preventive effects on OVX-induced bone loss of rats in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Wild RA, Buchamain JR, Myers C et al (1987) Declining adrenal androgen an association with bone loss in aging woman. Proc Soc Exp Biol Med 186:335–360

    Google Scholar 

  2. Cooper C, Melton J III (1995) Epidemiology of osteoporosis. Trends Endocrinol Metab 3:224–229

    Google Scholar 

  3. Promislow JHE, Goodman-Gruen D, Barret-Connor E et al (2002) Retinol intake and bone mineral density in the elderly: the rancho brenardo study. J Bone Miner Res 17:1349–1358

    Article  PubMed  CAS  Google Scholar 

  4. Bonjour J-P, Schurch M-A, Rozzori R (1996) Nutritional aspects of hip fractures. Bone 18:1395–1445

    Article  Google Scholar 

  5. Yamaguchi M (2002) Isoflavone and bone metabolism; Its cellular mechanism and preventive role in bone loss. J Health Sci 48:209–222

    Article  CAS  Google Scholar 

  6. Yamaguchi M (2006) Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 126:1117–1137

    Article  PubMed  CAS  Google Scholar 

  7. Lai YL, Yamaguchi M (2006) Phytocomponent p-hydroxycinnamic acid stimulates bone formation and inhibits bone resorption in rat femoral tissues in vitro. Mol Cell Biochem 292:45–52

    Article  PubMed  CAS  Google Scholar 

  8. Lai YL, Yamaguchi M (2007) Phytocomponent p-hydroxycinnamic acid inhibits osteoclast-like cell formation in mouse bone marrow cultures. Int J Mol Med 19:123–128

    PubMed  Google Scholar 

  9. Lai YL, Yamaguchi M (2006) Oral administration of phytocomponent p-hydroxycinnamic acid has anabolic effects on bone calcification in femoral tissues of rats in vivo. J Health Sci 52:308–312

    Article  CAS  Google Scholar 

  10. Yamaguchi M, Uchiyama S, Lai YL (2007) Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats. Int J Mol Med 19:803–807

    PubMed  CAS  Google Scholar 

  11. Uchiyama S, Yamaguchi M (2006) Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. Int J Mol Med 17:15–20

    PubMed  CAS  Google Scholar 

  12. Yamaguchi M, Oishi H, Suketa Y (1987) Stimulatory effect of zinc on bone formation in tissue culture. Biochim Pharmacol 36:4007–4012

    Article  CAS  Google Scholar 

  13. Walter K, Schutt C (1965) Acid and alkaline phosphatase in serum. In: Bergmeyer HV (ed) Methods of enzymatic analysis, vol 1–2. Academic Press, New York, pp 856–860

    Google Scholar 

  14. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  15. Flanagan B, Nichols G Jr (1962) Metabolic studies of bone in vitro. IV. Collagen biosynthesis by surviving bone fragments in vitro. J Biol Chem 237:3687–3692

    Google Scholar 

  16. Ceriotti G (1955) Determination of nucleic acids in animal tissues. J Biol Chem 214:39–77

    Google Scholar 

  17. Majeska RJ, Wuthier RE (1975) Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochem Biophys Acta 391:51–60

    PubMed  CAS  Google Scholar 

  18. Canalis E, Centrella M, Buech W (1989) Insulin-like factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60–65

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayoshi Yamaguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamaguchi, M., Lai, Y.L., Uchiyama, S. et al. Oral administration of phytocomponent p-hydroxycinnamic acid prevents bone loss in ovariectomized rats. Mol Cell Biochem 311, 31–36 (2008). https://doi.org/10.1007/s11010-007-9689-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-007-9689-x

Keywords

Navigation